Cinqair — Cigna
Severe asthma with an eosinophilic phenotype
Preferred products
- Fasenra
- Nucala
Initial criteria
- Patient meets the standard Immunologicals – Cinqair Prior Authorization Policy criteria; AND
- Patient meets ONE of the following (i or ii):
- i. Patient has tried ONE of Fasenra or Nucala; OR
- ii. Patient is currently receiving Cinqair.
Approval duration
per respective Immunologicals Prior Authorization Policy